Cyfuse Biomedical K.K.

4892・Growth Market・Pharmaceuticals

Official website

Cyfuse Biomedical K.K.

4892・Growth Market・Pharmaceuticals

Official website

Cyfuse Biomedical K.K.4892

Reference Indicators

Market Cap

53¥100M

P/E (Forecast)

—

P/B

1.9x

Dividend Yield (Forecast)

0.00%

ROE

-28.7%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Net Sales	374	61	54	230
Cost of Sales	132	23	37	117
Gross Profit	241	37	16	113
SG&A Expenses	666	735	912	942
Operating Income	-425	-697	-896	-828
Non-operating Income	47	131	46	108
Non-operating Expenses	55	20	20	41
Ordinary Income	-433	-586	-869	-761
Extraordinary Losses	38	—	—	—
Pre-tax Income	-471	-586	-869	-761
Income Taxes	2	3	2	2
Net Income	-473	-589	-872	-763
EBITDA	-370	-659	-860	-792
Gross Margin	64.5%	61.8%	30.9%	49.3%
Operating Margin	-113.5%	-1141.2%	-1645.9%	-358.5%
ROA	-9.8%	-14.0%	-24.8%	-17.9%
ROE	-12.6%	-18.4%	-35.0%	-28.7%